Reflections on screening mammography and the early detection of breast cancer

Current Oncology

Volumn 21, Issue 5, 2014, Pages 210-214

  Narod, Steven A ^a,b   Foulkes, William D ^b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SCREENING; EARLY DIAGNOSIS; HUMAN; MAMMOGRAPHY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; UTERINE CERVIX CANCER;

EID: 84907726462     PISSN: 11980052     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.2068     Document Type: Article

References (30)

1. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366.
2. Tabár L, Chen THH. We do not want to go back to the dark ages of breast cancer screening [Web letter]. BMJ Response London, U.K.: BMJ; 2014. [Available online at: http://www. bmj.com/content/348/bmj.g366/rr/686788; cited August 2, 2014]
3. Tabár L. A failure from the beginning [Web letter]. BMJ Response London, U.K.: BMJ; 2014. [Available online a t: http://www.bmj.com/content/348/bmj.g366/rr/687126; cited August 2, 2014]
4. Borgen PI. The real tragedy . [Web letter]. BMJ Response London, U.K.: BMJ; 2014. [Available online at http://www. bmj.com/content/348/bmj.g366/rr/686662; cited August 2, 2014]
5. Fand Incollingo B. Canadian Breast Screening Study Reignites Controversy Over Mammograms [Web article]. Philadelphia, PA: OncLive; 2014. [Available online at: http://www.onclive. com/conference-coverage/mbcc-2014/Canadian-Breast- Screening-Study-Reignites-Controversy-Over-Mammograms; cited cited August 2, 2014]
6. Kopans DB. Having been one of the experts called on in 1990 to review . [Web letter]. BMJ Response London, U.K.: BMJ; 2014. [Available online at: http://www.bmj.com/content/348/ bmj.g366/rr/686292; cited August 2, 2014]
7. Kopans DB. Arguments against mammography screening continue to be based on faulty science. Oncologist 2014;19:107-12.
8. Narod SA, Thompson DW, Jain M, Wall C, Green LM, Miller AB. Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study. Eur J Cancer 1991;27:1411-16.
9. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992;147:1459-76.
10. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477-88.
11. Mukherjee S. The Emperor of All Maladies: A Biography of Cancer. New York, NY: Scribner; 2010.
12. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260:658-63.
13. Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
14. Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
15. Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-62.
16. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-25.
17. Warner E, Hill K, Causer P, et al. Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 2011;29:1664-9.
18. Passaperuma K, Warner E, Causer PA, et al. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer 2012;107:24-30.
19. Narod SA. Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Curr Oncol 2012;19:249-53.
20. Grunfeld E, Dhesy-Thind S, Levine M on behalf of the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-20.
21. Narod SA. Bilateral breast cancers. Nat Rev Clin Oncol 2014;11:157-66.
22. Schaapveld M, Visser O, Louwman WJ, et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 2008;110:189-97.
23. King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg 2011;254:2-7.
24. Foulkes WD, Reis-Filho JS, Narod SA. Tumor size and survival in breast cancer-a reappraisal. Nat Rev Clin Oncol 2010;7:348-53.
25. Dent R, Valentini A, Hanna W, et al. Young at local recurrence predicts breast cancer mortality. Clin Oncol 2014;:[in press].
26. Woods WG, Tuchman M. Neuroblastoma: the case for screening infants in North America. Pediatrics 1987;79:869-73.
27. Woods WG, Gao RN, Shuster JJ, et al. S creening o f i nfants and mortality due to neuroblastoma. N Engl J Med 2002;346:1041-6.
28. Suita S, Zaizen Y, Sera Y, et al. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan. J Pediatr Surg 1996;31:555-8.
29. Narod SA. Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening. Breast Cancer Res Treat 2011;128:259-66.
30. Houvenaeghel G, Goncalves A, Classe JM, et al. Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study. Ann Oncol 2014;25:623-8.